Clinical analysis of 23 patients pathologically diagnosed with primary and secondary pulmonary enteric adenocarcinoma

Affiliations

¹ Graduate College of Fujian Medical University, Fuzhou, Fujian 350025, China.
² Pathology Department, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army, Fujian Medical University, Fuzhou, Fujian 350025, China.
³ Department of Respiratory and Critical Care Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army, Fujian Medical University, Fuzhou, Fujian 350025, China.
⁴ Respiratory Department, Zhangzhou Zhengxing Hospital, Zhangzhou, Fujian 363000, China.
⁵ Medical Imaging Center, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army, Fujian Medical University, Fuzhou, Fujian 350025, China.

Lei Gu et al. Chin Med J (Engl). 2019.

. 2019 Jun 5;132(11):1368-1369.

doi: 10.1097/CM9.0000000000000266.

¹ Graduate College of Fujian Medical University, Fuzhou, Fujian 350025, China.
² Pathology Department, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army, Fujian Medical University, Fuzhou, Fujian 350025, China.
³ Department of Respiratory and Critical Care Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army, Fujian Medical University, Fuzhou, Fujian 350025, China.
⁴ Respiratory Department, Zhangzhou Zhengxing Hospital, Zhangzhou, Fujian 363000, China.
⁵ Medical Imaging Center, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army, Fujian Medical University, Fuzhou, Fujian 350025, China.

Abstract

Supplemental Digital Content is available in the text

1. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc 2011; 8:381–385. doi: 10.1513/pats.201107-042ST. - PubMed
1. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015; 10:1243–1260. doi: 10.1097/JTO.0000000000000630. - PubMed
1. Chen M, Liu P, Yan F, Xu S, Jiang Q, Pan J, et al. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy. J Transl Med 2018; 16:81.doi: 10.1186/s12967-018-1449-z. - PMC - PubMed
1. Tsao AS, Scagliotti GV, Bunn PA, Jr, Carbone DP, Warren GW, Bai C, et al. Scientific advances in lung cancer 2015. J Thorac Oncol 2016; 11:613–638. doi: 10.1016/j.jtho.2016.03.012. - PubMed
1. Zheng D, Wang R, Zhang Y, Pan Y, Cheng X, Cheng C, et al. The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations. Onco Targets Ther 2016; 9:833–843. doi: 10.2147/OTT.S96834. - PMC - PubMed